SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists

OptimizeRx Corp (OPRX)

NASDAQ: OPRX · Real-Time Price · USD
8.27-0.28 (-3.27%)
 
Market Cap155.19M-54.7%
Revenue (ttm)n/a
Net Incomen/a
EPSn/a
Shares Out18.77M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume32,809
Open8.52
Previous Close8.55
Day's Range8.25 - 8.52
52-Week Range4.54 - 22.25
Betan/a
AnalystsBuy
Price Target10.25(+23.94%)
Earnings Daten/a
-3.27% (1D)
No price history available.
Insider Score
––Not scored
OPRX Insider Score

Insiders here have filed 11 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.

About OPRX

OptimizeRx Corporation operates as a digital healthcare technology company. It offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, limited distribution drug information, and patient support program messaging through healthcare professionals; and media execution solutions, which deliver messages through consumer omnichannel network, including through programmatic display, programmatic connected television/over-the-top, programmatic social media, addressable television, digital out-of-home, programmatic audio, and email/direct mail. The company also offers pharmacy alerts, which flag pharmacies that have prescription medications in stock; and financial messaging solutions, which provide prescribers visibility to branded copay offers for patients directly within electronic health record systems and ePrescribing platforms. The company was founded in 2006 and is headquartered in Waltham, Massachusetts.

Address
260 Charles Street, Waltham, MA, 02453, United States
Market Cap
155 million
Employees
132
Industrial Classification
Health Information Services
1 Day
-3.27%
5 Days
-1.43%
1 Month
+15.34%
6 Months
+34.25%
1 Year
-54.66%

$OPRX stock is featured in our Insider Trades datasets.

→ All Stock Lists

Recently reported changes in OPRX holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by OPRX's directors and management

Net Shares Purchased by Insiders−1−102025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

OPRX Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New OPRX patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to OPRX from public contracts

Source: USAspending.gov

OPRX Insider Score

Our composite score: insider buying, sector, volume, tone & dilution

No Insider Score for OPRX yet — no open-market insider buys or sells in the last 90 days.

Bull Case vs Bear Case

AI-generated from OPRX’s recent data — informational, not investment advice

Generating analysis…

Recent Insider Activity

Buys
0
Sells
0
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.